Nanoneedle-Based Drug Delivery Systems: Pharmacological Mechanisms, Targeted Therapeutics, and Translational Perspectives
International Journal of Drug Delivery Technology · 25.05.2026 · 16 (36s)
DOI: 10.25258/ijddt.16.36s.52 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, erschienen am 25.05.2026. Verfasst von Aishiq Hussain Ganie und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Nanoneedle-based drug delivery systems have emerged as a transformative paradigm in nanomedicine, offering unprecedented precision in the spatiotemporal control of therapeutic agent administration at the cellular and subcellular levels. Distinct from conventional microneedle platforms, nanoneedles defined by tip diameters typically below 100 nm and aspect ratios exceeding 10:1 is uniquely capable of penetrating biological membranes through endocytosis-independent mechanisms, enabling direct cytosolic and, in select configurations, intranuclear cargo delivery without triggering lysosomal degradation. This review provides a comprehensive and critically analytical account of the structural taxonomy, fabrication strategies, drug loading modalities, and pharmacological implications of nanoneedle-based systems. Emphasis is placed on the mechanistic underpinnings of cell membrane penetration, intracellular transport kinetics, and stimuli-responsive payload release, alongside their consequent effects on pharmacokinetic and pharmacodynamic profiles. Therapeutic applications spanning oncology, neurological disorders, diabetes mellitus, vaccine immunopharmacology, and gene therapy are examined, with particular attention to recent advances published between 2020 and 2026. A critical comparative analysis against established nanocarrier platforms, including liposomes, polymeric nanoparticles, and lipid nanoparticles, is undertaken to contextualize the distinct mechanistic and clinical advantages of nanoneedles. Translational barriers, including regulatory classification ambiguity, scalability constraints, and long-term biocompatibility concerns, are discussed alongside emerging technologies such as artificial intelligence-assisted design and biosensing-integrated smart nanoneedle systems. The review identifies key research gaps and articulates a prospective roadmap for the clinical translation of nanoneedle technology, underscoring its potential to redefine precision pharmacotherapy.
Zitieren
APA
Ganie, A. H., Golwala, S. S., Khanum, K. F., KR, P., Patel, J. Z., B, S. T., & Raza, M. H. (2026). Nanoneedle-Based Drug Delivery Systems: Pharmacological Mechanisms, Targeted Therapeutics, and Translational Perspectives. International Journal of Drug Delivery Technology, 16(36s). https://doi.org/10.25258/ijddt.16.36s.52
Vancouver
Ganie AH, Golwala SS, Khanum KF, KR P, Patel JZ, B ST, et al. Nanoneedle-Based Drug Delivery Systems: Pharmacological Mechanisms, Targeted Therapeutics, and Translational Perspectives. International Journal of Drug Delivery Technology. 2026;16(36s). doi:10.25258/ijddt.16.36s.52
BibTeX
@article{Ganie2026,
author = {Ganie, Aishiq Hussain and Golwala, Shikha Samirbhai and Khanum, Khamer Fathima and KR, Prajwal and Patel, Jofrin Zakirhusen and B, Shamreen Taj and Raza, Mohammed Hasan},
title = {Nanoneedle-Based Drug Delivery Systems: Pharmacological Mechanisms, Targeted Therapeutics, and Translational Perspectives},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {36s},
doi = {10.25258/ijddt.16.36s.52}
}
EUVIMED